| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |